Technicals
MovingAverage
Candlestick
PivotPoint
Fundamentals
Fin Statements
Beta&Vols
Tech ChartsStock Analysis of Lyka Labs (LYKALABS) - Birds Eye View
Overview
| Code | LYKALABS |
| Close | 115.65 |
| Change | -0.670 / 0.576 % |
| Volume | 53679.00 |
| Vol Change | 25025.00 / 87.34 % |
| Industry | Drugs & Pharma |
| Sector | Healthcare |
TSR Strength Index
| Technical Strength | Neutral |
| Growth Index | No Significant Growth |
| Value Index | Very Low Value Stock |
| Profitability Index | Low Profitability Stock |
| Stability Index | Good Stability |
Fundamental View of Lyka Labs
PE (TTM)
50.42
Very PoorPrice / Book
4.62
Very PoorPrice / Sales
2.92
PoorPiotroski F Score
6.0
GoodMarket Cap
412.75 (Cr)
Enterprise Value
430.62 (Cr)
ROA (TTM)
4.85
Not GoodROE (TTM)
9.16
Not GoodNet Margin (TTM)
5.79
Not GoodRevenue
24.56 %
1385.00 MNet Profit
418.47 %
79300.00 KDebt to Equity
0.186
ExcellentAltman Z Score
4.59
Very GoodQuick Ratio
1.18
IndecisiveCash Ratio
0.0287
PoorHighs/Lows of Lyka Labs
| Period | Old price | Stock Return | Nifty 50 | High | Low | High Date | Low Date |
|---|---|---|---|---|---|---|---|
| One Week | 119.30 | 3.06 % | 1.56 % | 121.52 | 115.00 | 03-Jun-25 | 09-Jun-25 |
| Two Week | 117.16 | 1.29 % | 0.408 % | 128.78 | 114.11 | 29-May-25 | 27-May-25 |
| One Month | 107.43 | 7.65 % | 4.56 % | 128.78 | 108.50 | 29-May-25 | 12-May-25 |
| Three Month | 110.85 | 4.33 % | 11.31 % | 128.78 | 96.80 | 29-May-25 | 07-Apr-25 |
| Six Months | 170.65 | 32.23 % | 1.97 % | 176.59 | 96.80 | 10-Dec-24 | 07-Apr-25 |
| One year | 106.90 | 8.19 % | 7.78 % | 176.59 | 96.80 | 10-Dec-24 | 07-Apr-25 |
| Two year | 105.75 | 9.36 % | 35.23 % | 176.59 | 96.80 | 10-Dec-24 | 07-Apr-25 |
| Five year | 17.20 | 572.38 % | 149.87 % | 267.00 | 16.00 | 24-Dec-21 | 12-Nov-20 |
| Ten year | 62.85 | 84.01 % | 212.91 % | 267.00 | 9.60 | 24-Dec-21 | 23-Mar-20 |
Technical View of Lyka Labs
RSI
50.26
NeutralMACD
1.48
Mild BearishADX
28.76
Mild BullishSuper Trend
107.37
Mild BullishWilliams %R
-89.50
BearishCCI
-29.66
NeutralEMA 5
116.83
Strong BearishEMA 15
116.85
WhipsawEMA 50
115.18
BullishEMA 100
119.70
WhipsawSMA 100
119.47
Mild BearishSMA 200
135.12
Mild BearishSMA 5 / 20
116.86 / 116.92
Mild BearishSMA 15 / 50
117.76 / 111.46
Mild BullishSMA 50 / 200
111.46 / 135.12
Strong BearishCharts of Lyka Labs
Returns of Lyka Labs with Peers
| Period / Stock | LYKALABS | ALBERTDAVD | MEDICO | BROOKS |
| 1 Week | -3.06% | 3.13% | -5.29% | -12.21% |
| 1 Mth | 7.65% | 3.28% | 0.099% | -0.214% |
| 3 Mth | 4.33% | -6.88% | -17.24% | 12.95% |
| 6mth | -32.23% | -41.76% | 1.16% | -7.63% |
| 1 Year | 8.19% | -29.90% | 32.92% | 69.18% |
| 2 Year | 9.36% | 44.28% | -39.11% | 107.44% |
| 5 Years | 572.38% | 59.10% | - | 299.66% |
| charts | - |
Compare Fundamentals of Lyka Labs with Peers
| Ratio / Stock | LYKALABS | ALBERTDAVD | MEDICO | BROOKS |
| PE | 50.42 | 27.60 | 36.13 | -27.66 |
| P/B | 4.62 | 1.20 | 6.56 | 6.87 |
| ROA | 4.85 | 3.33 | 9.90 | -17.07 |
| ROE | 9.16 | 4.33 | 18.15 | -24.84 |
| Debt To Equity | 0.186 | 0 | 0 | 0.0013 |
| Revenue | 1385.00 M 24.56 % | 3457.70 M 4.60 % | 1509.40 M 4.15 % | 0 100.00 % |
| Net Income | 79300.00 K 418.47 % | 172000 K 77.19 % | 100900 K 21.71 % | 0 100.00 % |
Technicals of Lyka Labs with Peers
| Technical / Stock | LYKALABS | ALBERTDAVD | MEDICO | BROOKS | - |
| ADX | 28.76 | 10.01 | 11.72 | 14.99 | |
| CMF | -0.0311 | 0.0177 | 0.099 | -0.096 | |
| MFI | 59.23 | 55.00 | 30.01 | 51.47 | |
| RSI | 50.26 | 54.51 | 40.27 | 44.05 | |
| MACD Abv Signal | False | True | False | False | |
| Price Above 50 MA | True | True | False | False | - |
| Price Above 200 MA | False | False | False | False | - |
About : Lyka Labs Limited
Address : Spencer Building, Mumbai, India, 400036
Tel : 91 22 6611 2200
URL : https://www.lykalabs.com
Code : LYKALABS, ISIN : INE933A01014, Exchange : NSE, Country : India
Fiscal Year End : March
Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients across various therapeutic segments in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant, proton pump inhibitor, nutraceuticals, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. It also offers contracted manufacturing services to various large pharmaceutical companies; and medical and technical assistance in the areas of manufacturing know how and manufacturing facilities, as well as technical data, such as molecule stability testing data, impurity profile, and BA/BE clinical study data. In addition, it provides products and services in therapeutic categories, such as intensive care, gastroenterology, anti-infective, anti-fungal, surgery care, cosmetologist, urology, wound care, and anesthesia. The company offers its products in various forms, including injections, creams, ointments, foams, gels, and lotions. It also exports its products. The company was incorporated in 1976 and is based in Mumbai, India.